证券代码：601089 证券简称：福元医药 公告编号：临 2025-056 北京福元医药股份有限公司 关于全资子公司营业执照变更的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 北京福元医药股份有限公司(以下简称"公司") 的全资子公司福 元药业有限公司于近日对经营范围进行了变更，并完成了工商变更登 记手续，取得了宣城市市场监督管理局换发的《营业执照》。变更后 《营业执照》基本登记信息如下： 名称：福元药业有限公司 类型：有限责任公司（非自然人投资或控股的法人独资） 法定代表人：黄河 注册资本：柒仟伍佰万圆整 成立日期：2001 年 09 月 03 日 住所：安徽省宣城市经济技术开发区 统一社会信用代码：913418007316537262 经营范围：许可项目：药品生产；药品委托生产；药品进出口； 消毒剂生产（不含危险化学品）；保健食品生产；化妆品生产；药品 互联网信息服务；供电业务（依法须经批准的项目，经相关部门批准 后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件 为准）一般项目：日用化学产品制造；日用 ...

证券日报网讯 8月13日晚间，福元医药发布公告称，公司的全资子公司福元药业有限公司于近日对经营 范围进行了变更，并完成了工商变更登记手续，取得了宣城市市场监督管理局换发的《营业执照》。 （文章来源：证券日报） ...

证券代码：601089 证券简称：福元医药 公告编号：临 2025-056 北京福元医药股份有限公司 关于全资子公司营业执照变更的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 北京福元医药股份有限公司(以下简称"公司") 的全资子公司福 元药业有限公司于近日对经营范围进行了变更，并完成了工商变更登 记手续，取得了宣城市市场监督管理局换发的《营业执照》。变更后 《营业执照》基本登记信息如下： 法定代表人：黄河 注册资本：柒仟伍佰万圆整 成立日期：2001 年 09 月 03 日 住所：安徽省宣城市经济技术开发区 经营范围：许可项目：药品生产；药品委托生产；药品进出口； 消毒剂生产（不含危险化学品）；保健食品生产；化妆品生产；药品 互联网信息服务；供电业务（依法须经批准的项目，经相关部门批准 后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件 为准）一般项目：日用化学产品制造；日用化学产品销售；化妆品批 发；化妆品零售；互联网销售（除销售需要许可的商品）；技术服务、 技术开发、技术咨询、技术交流、技术转让、技术 ...

资金流向方面，今日主力资金净流出2896.47万元，占比成交额5.26%。其中，超大单净流出1086.97万 元、占成交额1.97%，大单净流出1809.50万元、占成交额3.29%，中单净流出流入1157.64万元、占成交 额2.1%，小单净流入1738.82万元、占成交额3.16%。 通过天眼查大数据分析，北京福元医药股份有限公司共对外投资了3家企业，参与招投标项目5000次， 知识产权方面有商标信息214条，专利信息142条，此外企业还拥有行政许可148个。 来源：金融界 福元医药最新一期业绩显示，截至2025一季报，公司营业总收入8.30亿元、同比增长3.46%，归属净利 润1.31亿元，同比减少1.47%，扣非净利润1.22亿元，同比减少1.16%，流动比率2.737、速动比率 2.441、资产负债率24.29%。 天眼查商业履历信息显示，北京福元医药股份有限公司，成立于1999年，位于北京市，是一家以从事医 药制造业为主的企业。企业注册资本48000万人民币，实缴资本48000万人民币。公司法定代表人为黄 河。 金融界消息 截至2025年8月12日收盘，福元医药（601089）报收于30.64元， ...

New Stock Listings - Tianfu Long (603406) issued at a price of 23.60[1] - Youli Intelligent (920007) issued at a price of 23.99[1] Rights Issues and Announcements - China Heavy Industry (601989) cash option declaration period from August 13, 2025[1] - China Shipbuilding (600150) acquisition request period from August 13 to August 15, 2025[1] - Shenkai Co., Ltd. (002633) offer declaration period from July 29 to August 27, 2025[1] - ST Kelly (300326) offer period from July 17 to August 15, 2025[1] - Fushun Special Steel (600399) offer period from August 12 to September 10, 2025[1] Abnormal Fluctuations - Multiple stocks reported abnormal fluctuations, including *ST Yushun (002289) and Changcheng Military Industry (601606)[2][3] - Notable fluctuations also reported for companies like Li De Man (300289) and Dongjie Intelligent (300486)[3]

Market Overview - On August 8, the chemical pharmaceutical sector rose by 0.24% compared to the previous trading day, with Lianhuan Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 3635.13, down 0.12%, while the Shenzhen Component Index closed at 11128.67, down 0.26% [1] Stock Performance - Notable declines in individual stocks include: - Shanghai Yizhong: closed at 72.23, down 5.42% with a trading volume of 80,000 shares and a turnover of 573 million yuan - Yifang Bio: closed at 39.80, down 5.37% with a trading volume of 203,000 shares and a turnover of 818 million yuan - Qianhong Pharmaceutical: closed at 10.19, down 4.77% with a trading volume of 1,197,800 shares and a turnover of 1.23 billion yuan [1] Capital Flow Analysis - The chemical pharmaceutical sector experienced a net outflow of 230 million yuan from institutional investors and a net outflow of 93.16 million yuan from retail investors, while retail investors saw a net inflow of 323 million yuan [1] - Key stocks with significant capital flow include: - Meinuohua: net inflow of 236 million yuan from institutional investors, with a 18.01% share - Lianhuan Pharmaceutical: net inflow of 197 million yuan from institutional investors, with a 13.40% share [2] - Other notable stocks include Han Yu Pharmaceutical and Bo Rui Pharmaceutical, with net inflows of 171 million yuan and 131 million yuan from institutional investors, respectively [2]

Group 1 - The stock price of Fuyuan Pharmaceutical as of August 7, 2025, is 26.92 yuan, down by 1.13 yuan or 4.03% from the previous trading day [1] - The opening price on the same day was 28.72 yuan, with a highest point of 28.99 yuan and a lowest point of 26.70 yuan, resulting in a trading volume of 274,783 hands and a transaction amount of 761 million yuan [1] - Fuyuan Pharmaceutical operates in the chemical pharmaceutical sector, focusing on drug research, production, and sales, with a product line covering multiple therapeutic areas and a business presence in Beijing [1] Group 2 - On August 7, the net outflow of main funds was 11.06 million yuan, with a cumulative net outflow of 21.21 million yuan over the past five trading days [1] - During intraday trading, the stock experienced rapid fluctuations, including a rebound of over 2% within five minutes at 9:53 AM, followed by a decline of over 2% within five minutes at 9:40 AM [1]

Group 1 - The innovative drug concept stocks experienced significant upward movement, with Rundu Co., Ltd. hitting the daily limit increase [1] - Haitian Pharmaceutical and Sunshine Nuohuo both rose over 10%, indicating strong market interest [1] - Other companies such as Huaren Health, Fuyuan Pharmaceutical, and Guangsheng Tang also saw notable gains, reflecting a broader trend in the sector [1]

Group 1 - The stock price of Fuyuan Pharmaceutical closed at 28.78 yuan on August 5, 2025, down 1.40% from the previous trading day, with a trading range of 7.64% [1] - The highest price during the day reached 30.00 yuan, while the lowest was 27.77 yuan, with a trading volume of 340,600 hands and a transaction amount of 980 million yuan, resulting in a turnover rate of 7.10% [1] - The company is primarily engaged in chemical pharmaceuticals and is registered in Beijing, with a total market capitalization of 13.814 billion yuan and a price-to-earnings ratio of 26.44 times, along with a price-to-book ratio of 4.01 times [1] Group 2 - On August 5, the net outflow of main funds was 131 million yuan, accounting for 0.95% of the circulating market value; however, over the past five trading days, there has been an overall net inflow of 20.8001 million yuan [1]

New Stock Issuance - The new stock issuance for Zhigao Machinery (证券代码: 920101) is priced at 17.41 CNY per share, effective from August 5, 2025[1] - China Heavy Industry (证券代码: 601989) has a cash option declaration period from August 13, 2025[1] - China Shipbuilding (证券代码: 600150) has a buyback request period from August 13 to August 15, 2025[1] Offer and Acquisition Periods - Shenkou Co., Ltd. (证券代码: 002633) has a tender offer period from July 29 to August 27, 2025[1] - ST Kelly (证券代码: 300326) has a tender offer period from July 17 to August 15, 2025[1] - Happiness Blue Ocean (证券代码: 300528) has a significant announcement on July 30, 2025[1] Market Volatility - There are reports of severe abnormal fluctuations for Tibet Tourism (证券代码: 600749) as of July 31, 2025[1] - ST Suwu (证券代码: 600200) also reported significant volatility on July 30, 2025[1] - The stock of ST YaTai (证券代码: 000691) is under observation for abnormal trading activities as of August 5, 2025[1]